Geode Capital Management LLC Purchases 109,904 Shares of Intuitive Surgical, Inc. $ISRG

Geode Capital Management LLC boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.4% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 8,188,685 shares of the medical equipment provider’s stock after buying an additional 109,904 shares during the period. Geode Capital Management LLC’s holdings in Intuitive Surgical were worth $4,429,590,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Tobam grew its stake in Intuitive Surgical by 666.7% during the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 40 shares during the period. TD Capital Management LLC boosted its holdings in shares of Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 45 shares in the last quarter. 1248 Management LLC bought a new position in shares of Intuitive Surgical during the 1st quarter worth approximately $30,000. Princeton Global Asset Management LLC acquired a new stake in shares of Intuitive Surgical during the 2nd quarter worth approximately $30,000. Finally, Bank of Jackson Hole Trust increased its stake in shares of Intuitive Surgical by 70.5% in the 1st quarter. Bank of Jackson Hole Trust now owns 75 shares of the medical equipment provider’s stock valued at $37,000 after acquiring an additional 31 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Price Performance

ISRG opened at $572.17 on Wednesday. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The firm has a market capitalization of $205.11 billion, a PE ratio of 75.68, a P/E/G ratio of 4.94 and a beta of 1.62. The company’s 50-day moving average is $476.01 and its 200 day moving average is $502.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. The firm had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company’s revenue for the quarter was up 22.9% on a year-over-year basis. During the same period in the previous year, the company posted $1.84 EPS. As a group, analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analyst Weigh In

A number of research firms have commented on ISRG. Jefferies Financial Group raised their price target on shares of Intuitive Surgical from $550.00 to $560.00 and gave the stock a “hold” rating in a report on Wednesday, October 22nd. Argus raised their target price on Intuitive Surgical from $600.00 to $630.00 in a research note on Monday, October 27th. Truist Financial set a $620.00 target price on Intuitive Surgical and gave the company a “buy” rating in a research report on Wednesday, October 22nd. Sanford C. Bernstein reiterated an “outperform” rating and issued a $685.00 price target on shares of Intuitive Surgical in a report on Tuesday, October 21st. Finally, Zacks Research raised Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research note on Friday, October 24th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $608.92.

Insider Buying and Selling at Intuitive Surgical

In related news, CEO David J. Rosa sold 24,500 shares of the stock in a transaction on Friday, October 24th. The stock was sold at an average price of $547.55, for a total value of $13,414,975.00. Following the completion of the sale, the chief executive officer directly owned 234,256 shares of the company’s stock, valued at approximately $128,266,872.80. This represents a 9.47% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, VP Fredrik Widman sold 2,067 shares of Intuitive Surgical stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $550.00, for a total transaction of $1,136,850.00. Following the transaction, the vice president directly owned 473 shares in the company, valued at $260,150. This represents a 81.38% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 98,078 shares of company stock valued at $51,445,892 in the last three months. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.